Kalderos works with stakeholders across the pharmaceutical supply chain to ensure the integrity of drug discount programs. In regards to Kalderos Review and Request, Kalderos is retained by drug manufacturers to work on the manufacturer’s behalf to review 340B discounts to 340B Program covered entity providers. Kalderos acts on behalf of the manufacturer to analyze 340B discounts to these providers and to provide information to manufacturers to allow them to determine whether a 340B discount to a provider is consistent with 340B Program rules and whether a prohibited duplicate discount scenario exists.